Compare

Hexarelin vs Semax

Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.

Last reviewed . By the PeptIQ team.

Observational reporting only — not medical advice. Does not recommend doses, protocols, or treatments.

Hexarelin

1224 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 48% · Mixed 44% · Unfavorable overall 8%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Appetite control
75
Energy
19
Mood
170
Focus
166
Sleep quality
76

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

GI discomfort
171
Dizziness
99
Fatigue
135
Nausea
162
Water retention
75

Self-reported dose per injection

Median bucket: 100–200 mcg · Most common: 100–200 mcg

Reports span 25–600 mcg

25–50
7
50–100
15
100–200
23
200–400
12
400–600
7

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

Common discussion topics

timing28stacking21side effects14hexarelin7

How repeat users are trending

Among repeat reporters, 58% said they felt similar to their last entry, 28% more positive, and 18% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 32 days · Based on 269 repeat reporters

Semax

1730 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 44% · Mixed 46% · Unfavorable overall 10%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Digestive comfort
-115
Skin appearance
-49
Appetite control
-41
Energy
-63
Mood
-88

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Flushing
-19
Headache
-150
GI discomfort
-76
Dizziness
-67
Fatigue
-88

Self-reported dose per injection

Median bucket: 0.4–0.6 mg · Most common: 0.4–0.6 mg

Reports span 0.05–3 mg

0.05–0.1 mg
4
0.1–0.2 mg
15
0.2–0.4 mg
19
0.4–0.6 mg
29
0.6–1 mg
19
1–2 mg
11
2–3 mg
3

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

Common discussion topics

timing14stacking32side effects10semax13

How repeat users are trending

Among repeat reporters, 54% said they felt similar to their last entry, 42% more positive, and 14% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 22 days · Based on 381 repeat reporters

Sources (11)

Published sources linked on the Hexarelin and Semax wiki pages.

  1. PubMed

    Hexarelin, a synthetic growth hormone-releasing peptide, vs GHRH in GH-deficient adults

    Ghigo E, Arvat E, Muccioli G, et al. Eur J Endocrinol. 1996

    Source
    Wiki study page →
  2. PubMed

    Hexarelin provides cardioprotective effects in rats

    Bisi G, Podio V, Valetto MR, et al. Growth Horm IGF Res. 2001

    Source
    Wiki study page →
  3. ClinicalTrials.gov

    Hexarelin studies on ClinicalTrials.gov

    ClinicalTrials.gov. Clinical trial registry. 2024

    Source
    Wiki study page →
  4. PubMed

    The cardiovascular action of hexarelin

    Mao Y, Tokudome T, Kishimoto I. Journal of geriatric cardiology : JGC. 2014

    Source
    Wiki study page →
  5. PubMed

    Semax, an analog of ACTH(4-7), regulates expression of immune response genes

    Dmitrieva VG, Povarova OV, Skvortsova VI, et al. Mol Genet Genomics. 2013

    Source
    Wiki study page →
  6. PubMed

    Semax, a synthetic analog of ACTH, shows neuroprotective properties

    Ashmarin IP, Nezavibatko VN, Levitskaya NG, et al. Neurosci Res. 2006

    Source
    Wiki study page →
  7. PubMed

    Semax affects BDNF expression and neuroplasticity

    Dolotov OV, Karpenko EA, Inozemtseva LS, et al. J Neurochem. 2008

    Source
    Wiki study page →
  8. PubMed

    Modulation of neuropathological pathways by bioactive peptides and proteins/polypeptides: Targeting oxidative stress in neurodegenerative diseases

    Giri S, Chandra P. Neuropeptides. 2025

    Source
    Wiki study page →
  9. PubMed

    [The efficacy of semax in the tretament of patients at different stages of ischemic stroke]

    Gusev EI, Martynov MY, Kostenko EV, et al. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2018

    Source
    Wiki study page →